The store will not work correctly when cookies are disabled.
1-(4-nitrophenyl)sulfonylpyrrolidine-2,5-dione
ID: ALA4854450
PubChem CID: 13704823
Max Phase: Preclinical
Molecular Formula: C10H8N2O6S
Molecular Weight: 284.25
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CCC(=O)N1S(=O)(=O)c1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C10H8N2O6S/c13-9-5-6-10(14)11(9)19(17,18)8-3-1-7(2-4-8)12(15)16/h1-4H,5-6H2
Standard InChI Key: FUUHKWWRHZIUGB-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
26.0882 -18.7665 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.3028 -19.5589 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
26.8818 -18.9769 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.2710 -20.5908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5254 -19.8141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8624 -19.3319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8611 -18.5147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7506 -21.2525 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.4538 -20.5908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2027 -19.8111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9094 -20.1103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7330 -20.9094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3388 -21.4605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1205 -21.2110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2930 -20.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6858 -19.8577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7268 -21.7607 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5048 -21.5108 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.5542 -22.5595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
9 4 1 0
4 5 1 0
5 6 1 0
6 10 1 0
6 7 2 0
4 8 2 0
9 10 1 0
5 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
17 19 1 0
14 17 1 0
M CHG 2 17 1 19 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 284.25 | Molecular Weight (Monoisotopic): 284.0103 | AlogP: 0.43 | #Rotatable Bonds: 3 |
Polar Surface Area: 114.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 0.54 | CX LogD: 0.54 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.45 | Np Likeness Score: -1.37 |
References
1. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |